Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP953325.RAbbplVyLkdttqfgmjvKe4NuI3iCnDF8mp1vEG_2PPWRI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP953325.RAbbplVyLkdttqfgmjvKe4NuI3iCnDF8mp1vEG_2PPWRI130_assertion type Assertion NP953325.RAbbplVyLkdttqfgmjvKe4NuI3iCnDF8mp1vEG_2PPWRI130_head.
- NP953325.RAbbplVyLkdttqfgmjvKe4NuI3iCnDF8mp1vEG_2PPWRI130_assertion description "[These data suggest that aberrant epigenetic modification of SFRP genes is one of the major mechanisms by which Wnt signaling is activated in human gastric cancer cells and sodium butyrate may modulate the SFRP1/2 expression through histone modification and promoter demethylation causing anti-tumor effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953325.RAbbplVyLkdttqfgmjvKe4NuI3iCnDF8mp1vEG_2PPWRI130_provenance.
- NP953325.RAbbplVyLkdttqfgmjvKe4NuI3iCnDF8mp1vEG_2PPWRI130_assertion evidence source_evidence_literature NP953325.RAbbplVyLkdttqfgmjvKe4NuI3iCnDF8mp1vEG_2PPWRI130_provenance.
- NP953325.RAbbplVyLkdttqfgmjvKe4NuI3iCnDF8mp1vEG_2PPWRI130_assertion SIO_000772 22246241 NP953325.RAbbplVyLkdttqfgmjvKe4NuI3iCnDF8mp1vEG_2PPWRI130_provenance.
- NP953325.RAbbplVyLkdttqfgmjvKe4NuI3iCnDF8mp1vEG_2PPWRI130_assertion wasDerivedFrom befree-2016 NP953325.RAbbplVyLkdttqfgmjvKe4NuI3iCnDF8mp1vEG_2PPWRI130_provenance.
- NP953325.RAbbplVyLkdttqfgmjvKe4NuI3iCnDF8mp1vEG_2PPWRI130_assertion wasGeneratedBy ECO_0000203 NP953325.RAbbplVyLkdttqfgmjvKe4NuI3iCnDF8mp1vEG_2PPWRI130_provenance.